Capital Impact Advisors’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8,229
| Closed | -$224K | – | 96 |
|
|
2023
Q4 | $224K | Buy |
+8,229
| New | +$224K | 0.29% | 90 |
|
|
2023
Q3 | – | Sell |
-12,600
| Closed | -$402K | – | 117 |
|
|
2023
Q2 | $402K | Hold |
12,600
| – | – | 0.44% | 110 |
|
|
2023
Q1 | $386K | Buy |
12,600
+445
| +4% | +$13.6K | 0.47% | 98 |
|
|
2022
Q4 | $475K | Buy |
12,155
+458
| +4% | +$17.9K | 0.46% | 84 |
|
|
2022
Q3 | $554K | Buy |
11,697
+2,766
| +31% | +$131K | 0.55% | 65 |
|
|
2022
Q2 | $346K | Buy |
8,931
+1,732
| +24% | +$67.1K | 0.32% | 139 |
|
|
2022
Q1 | $413K | Sell |
7,199
-273
| -4% | -$15.7K | 0.3% | 150 |
|
|
2021
Q4 | $595K | Buy |
+7,472
| New | +$595K | 0.41% | 75 |
|
|
2021
Q1 | – | Sell |
-25,000
| Closed | -$2.04M | – | 113 |
|
|
2020
Q4 | $2.04M | Buy |
+25,000
| New | +$2.04M | 0.5% | 78 |
|